Transient cerebral ischemia and risk of ischemic cerebral infarction
DOI:
https://doi.org/10.51481/amc.v48i1.214Keywords:
cerebral isquemia, neurologic emergency, strokeAbstract
secondary to an acute arterial occlusion of an specific vas- cular territory, the remaining 20% are of hemorrhagic ori- gin. The neurological impairment secondary to strokes, in these patients is the main cause of chronic disability and is related with high morbility and mortality. Although many individuals have an acute ischemic stroke, other patients will have 1 or more events of transient ischemic attacks, indicating that they are at risk for an ischemic stroke in a brief period of time. This arti- cle reviews the current medical knowledge, and is written especially for general practitioners and emergency physi- cians, so they can recognize the patients at risk and prevent them from having an ischemic stroke. Transient ischemic attacks must be considered a neurological emergency.Downloads
References
Claiborne S.Transient Ischemic Attack. N Engl J Med 2002;21:1687-1692.
Johnson RT, Griftin JW and Mcarthur JC. Current therapy inNeurologic disease. Sixth edition. USA: Mosby, 2002.
The National Institute of Neurological Disorder and Stroke rt-PAStroke Study Group. Tissue plasminogen activator for acute ischemicstroke. N Engl J Med 1995;333:1581-1587.
Bricker ME, MD. Cardioembolic Stroke. Am J Med 1996;100:465-474.
Hankey G, Slattery J, Warlow C. Transient ischaemic attacks: whichpatients are at high (and low) risk of serious vascular events? JNeurol Neurosurg Psychiatry 1992;55:640-652.
Wolf P, Abbot R, Kannel W. Atrial fibrillation as an independent riskfactor for stroke: the Framingham Study. Stroke 1991;22:983-988.
Wolf P, Mitchell J, Baker C, Kannel W, D`Angostino R. Impact ofatrial fibrillation on mortality, stroke, and medical costs. Arch InternMed 1998;158:229-234.
Norris J. Risk of cerebral infarction, myocardial infarction and vas-cular death in patients with asymptomatic carotid disease, transientischemic attack and stroke. Cerebrovasc Dis 1992;2(suppl):2-5.
Adams HP. Treating ischemic stroke as an emergency. ArchNeurol.1998;55:457-461.
Barinagarrementería F, Cantú C. Enfermedad Vascular Cerebral.México: McGraw- Hill Interamericana, 1999.
Lee J, Zipfel G, Choi D. The changing landscape of ischaemic braininjury mechanism. Nature 1999;399:Suppl:A7-A14.
Brott T, Bogousslovsky J. Treatment of acute ischemic stroke. N EngJ Med 2000;343:710-722.
Kristian T, Siesjo B. Calcium in ischemic cell death. Stroke1998;29:705-718.
Guidelines for the management of transient ischemic attacks. Fromthe Ad Hoc Committee on Guidelines of the Management ofTransient Ischemic Attacks of the Stroke Council of the AmericanHeart Association. Stroke 1994;25:1320-1335.
Adams H Jr, del Zoppo G, von Kummer R. Management of stroke: apractical guide for the prevention, evaluation and treatment of acutestroke. USA: Professional Communications NC, 2002.
Donders R, Kappelle L, Derksen R. Transient monocular blindnessand antiphospholipid antibodies in systemic lupus erythematosus.Neurology 1998;51:535-540.
Johnston S, Gress D, Browner W, Sidney S. Short-term prognosisalter emergency department diagnosis of TIA. JAMA2000;284:2901-2906.
Dennis M, Bamford J, Sandercock P, Warlow C. Prognosis of tran-sient ischemic attacks in the Oxfordshire Community Stroke Project.Stroke 1990;21:848-853.
Streifler J, Eliasziw M, Benavente O. The risk of stroke in patientswith first-ever retinal vs. hemispheric transient ischemic attacks andhigh-grade carotid stenosis: North American Symptomatic CarotidEndarterectomy Trial. Arch Neurol 1995;52:246-249.
O`Leary D, Polak J, Kronmal R. Carotid-artery intima and mediathickness as a risk factor for myocardial infarction and stroke in olderadults. Cardiovascular Health Study Collaborative Reserch Group. NEng J Med 1999;340:14-22.
Hart R, Palacio S, Pearce L. Atrial fibrillation, stroke and acuteantithrombotic therapy. Analysis of randomized clinical trials. Stroke2002;33:2722-2727.
Paciaroni M, Bogousslovsky J. Clopidogrel for cerebrovascular pre-vention. Cerebrovasc Dis 1999;9:253-260.
Adams H. Emergent use of anticoagulation for treatment of patientswith ischemic stroke. Stroke 2002;33:856-861.
Tanne D, Turgerman D, Adler Y. Management of acute ischemicstroke in the elderly. Drugs 2001;32:1074-1078.
Hachinski V, Graffagnino C, Beaudry M. Lipids and Stroke: a para-dox resolved. Arch Neurol 1996;53:303-308.
Plehn J, Davis B, Sacks F. Reduction of stroke incidence aftermyocardial infarction with pravastatina: the Cholesterol andRecurrent Events (CARE) Study. The care investigators. Circulation1999;99:216-223.
Blauw G, Lagaay A, Smelt A, Westendorp R. Stroke, statins, and cho-lesterol. A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductasa inhibitors. Stroke1997;28:946-950.
Biller J, Feinberg W, Castaldo J. Guidelines for carotid endarterecto-my: a statement for healthcare professionals from a Special WritingGroup of the Stroke Council, American Heart Association.Circulation 1998;97:501-509.
Sacks D, Connors J. Carotid Stent Placement, Stroke Prevention, andTraining. Radiology 2004;234:49-52.
Connors J, Saks D, Furlan A, Selman W, Russell E, Stieg P et al.Training, Competency, and Credentialing Standards for DiagnosticCervicocerebral Angiography, Carotid Stenting, and CerebrovascularIntervention : A Joint Statement from the American Academy ofNeurology, American Association of Neurological Surgeons,American Society of Interventional and Therapeutic Radiology,American Society of Neuroradiology, Congress of NeurologicalSurgeons, AANS/CNS Cerebrovascular Section, and Society ofInterventional Radiology. Radiology 2005;234:26-34.
Yadav J, Wholey M, Kuntz R, Fayad P, Katzen B, Mishkel G et al.Protected Carotid-Artery Stenting versus Endarterectomy in High-Risk Patients. N Eng J Med 2004;351:1493-1501
Lin P, Bush R, Lubbe D, Cox M, Zhou W, McCoy S et al. Carotidartery stenting with routine cerebral protection in high-risk patients.Am J Surg 2004;188:644-652.
Solenski N. Transient ischemic attacks: Part II. Treatment. Am FamPhysician 2004;69:1681-1688.
Downloads
Published
Issue
Section
License
Copyright (c) 2008 Acta Médica Costarricense
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Los autores que publican en la revista Acta Médica Costarricense pueden distribuir, copiar, remezclar, retocar, leer, descargar, imprimir, buscar y crear a partir de su obra de modo no comercial, indicando los créditos a la revista y sus autores y compartir su obra en las mismas condiciones. Para ello se aplica la licencia Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional(CC BY-NC-SA 4.0)
